The fact
The company operates in innovative therapies and drug development.
Its market performance continues to be monitored by investors specialized in the healthcare sector.
37 sources — click a link to read an article on the topic:
Story timeline
Apr 13Banque de France évalue l'impact limité de la guerre en Iran sur l'activité économique en mars 2024
Apr 14Genfit: French biotech status on April 12, 2026this article